ADI-001 Phase 1 Trial Success
Resolves: Successful completion of Phase 1 trial with no major safety concerns reported.
sec_filing· Clinical Trial Progress
ADI-001 Phase 1 Trial Success
Market overview
Derived from Adicet Bio, Inc. (ACET) (CIK 0001720580) 8-K filing analysis
Clinical Trial Progress prediction market
- Implied probability (Yes)
- 65%
- Closes
- 2027-09-28
About this prediction
Resolution criteria
Successful completion of Phase 1 trial with no major safety concerns reported.
More Clinical Trial Progress markets
No one's made a Conviction call on this yet. Be the first to call it →
Loading…